Horse Cloning Lawsuit Heads to Court
A lawsuit challenging American Quarter Horse Association (AQHA) rules preventing cloned horses from being registered is headed to court this week.
Some owners have used the cloning process—which was first performed on horses in 2003—to preserve their animals’ bloodlines, particularly those of high-performance equines. In response to cloning as a way to preserve bloodlines, some breed associations ruled on whether or not cloned horses can be included in their breed registries. In 2004 the AQHA board of directors approved Rule 227(a), which prohibits cloned horses or their offspring from being included in the organization’s breed registry.
Last year Jason Abraham and two of his related companies, Abraham & Veneklasen Joint Venture and Abraham Equine Inc., filed suit against the AQHA in the U.S. District Court for the Northern District of Texas, Amarillo Division. The complaint asks the court to order the AQHA to remove Rule 227(a) on grounds that the ban on registering cloned horses and their offspring violates antitrust laws.
Atty. Nancy Stone, who represents Abraham & Veneklasen Joint Venture, was unavailable for comment. Neither Abraham nor fellow plaintiff Gregg Veneklasen, DVM, were available for comment.
AQHA spokesman Tom Persechino said opening statements in that lawsuit are expected to be heard on July 16. Persechino said that the AQHA stands by its 2004 membership vote.
“As an association whose members voluntarily join and come together for their love, shared interest in and enjoyment of the American Quarter Horse, AQHA will strongly defend those members rights to determine rules for their Association,” said Persechino. “One such rule is that those members do not want cloned horses and their reasons for not wanting them are varied.”
According to the AQHA website, the association opposed clone registries on several grounds including that cloning does not improve the breed and that elite horses might be cloned repeatedly for use in breeding programs.
Courtesy: Pat Raia